<p>CIB1-shRNA transduction in HMVEC-d cells resulted in the following consequences which are depicted by the red lines: (i) CIB1 protein level was reduced by >90%; (ii) CIB1 association with EphA2 and the associated KSHV induced Src-PI3-K-c-Cbl signal complex was significantly reduced; (iii) KSHV induced EphA2 activation was not sustained and as a consequence, downstream Src and Erk1/2 signal amplification was significantly abrogated; (iv) EphA2 association with Src-PI3-k-c-Cbl signal complex was substantially reduced; (v) EphA2 association with actin modulating myosin IIA and alpha actinin-4 were almost abolished, (vi) as a consequence, actin cytoskeletal rearrangement and membrane blebbing was inhibited, which (vii) impaired KSHV macropin...
<p>A model illustrating the regulation of cellular transformation by KSHV miRs.</p
<p>(<b>A</b>) Control sh-RNA or EphA2-sh-RNA-transduced or untransduced HFF cells were serum starved...
<p>(A) Treatment with PP1 analog inhibits KSHV entry and intracellular trafficking in a dose-depende...
<p>(A) Serum-starved (8 h) HMVEC-d cells or CIB1-shRNA transduced HMVEC-d cells were either mock or ...
<p>KSHV entry into HMVEC-d cells begins with <b>(1)</b> the virus attachment to the cell surface hep...
KSHV envelope glycoproteins interact with cell surface heparan sulfate and integrins, and activate F...
<p>(A) HMVEC-d cells were either untransduced or transduced with sh-control or sh-CIB1 expressing le...
<p>(A) Untransduced or CIB1 sh-RNA transduced HMVEC-d cells were incubated with KSHV (20 DNA copies/...
<p>(A) Untransduced, control or CIB1-shRNA transduced HMVEC-d cells were infected with KSHV (20 DNA ...
<p>(<b>A</b>) Control or EphA2 shRNA-transduced HFF cells were either mock infected (UI) or infected...
<p>(A) Serum-starved (8 h) HMVEC-d cells were either mock or KSHV infected (20 DNA copies/cell) for ...
Kaposi’s sarcoma-associated herpesvirus (KSHV) interacts with cell surface receptors, such as hepara...
<p>(A) Control shRNA or CIB1-shRNA transduced HMVEC-d cells were infected with KSHV (20 DNA copies/c...
<p>(<b>A</b>) Immediately after infection, MLL/SET containing complexes are recruited to viral episo...
<p>(a) Upon KSHV infection, membrane-localized AR translocates into the nucleus. HUVECs were left un...
<p>A model illustrating the regulation of cellular transformation by KSHV miRs.</p
<p>(<b>A</b>) Control sh-RNA or EphA2-sh-RNA-transduced or untransduced HFF cells were serum starved...
<p>(A) Treatment with PP1 analog inhibits KSHV entry and intracellular trafficking in a dose-depende...
<p>(A) Serum-starved (8 h) HMVEC-d cells or CIB1-shRNA transduced HMVEC-d cells were either mock or ...
<p>KSHV entry into HMVEC-d cells begins with <b>(1)</b> the virus attachment to the cell surface hep...
KSHV envelope glycoproteins interact with cell surface heparan sulfate and integrins, and activate F...
<p>(A) HMVEC-d cells were either untransduced or transduced with sh-control or sh-CIB1 expressing le...
<p>(A) Untransduced or CIB1 sh-RNA transduced HMVEC-d cells were incubated with KSHV (20 DNA copies/...
<p>(A) Untransduced, control or CIB1-shRNA transduced HMVEC-d cells were infected with KSHV (20 DNA ...
<p>(<b>A</b>) Control or EphA2 shRNA-transduced HFF cells were either mock infected (UI) or infected...
<p>(A) Serum-starved (8 h) HMVEC-d cells were either mock or KSHV infected (20 DNA copies/cell) for ...
Kaposi’s sarcoma-associated herpesvirus (KSHV) interacts with cell surface receptors, such as hepara...
<p>(A) Control shRNA or CIB1-shRNA transduced HMVEC-d cells were infected with KSHV (20 DNA copies/c...
<p>(<b>A</b>) Immediately after infection, MLL/SET containing complexes are recruited to viral episo...
<p>(a) Upon KSHV infection, membrane-localized AR translocates into the nucleus. HUVECs were left un...
<p>A model illustrating the regulation of cellular transformation by KSHV miRs.</p
<p>(<b>A</b>) Control sh-RNA or EphA2-sh-RNA-transduced or untransduced HFF cells were serum starved...
<p>(A) Treatment with PP1 analog inhibits KSHV entry and intracellular trafficking in a dose-depende...